Molecular Templates (MTEM)
(Delayed Data from NSDQ)
$1.41 USD
+0.01 (0.43%)
Updated Aug 5, 2024 03:59 PM ET
After-Market: $1.41 0.00 (0.28%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
MTEM 1.41 +0.01(0.43%)
Will MTEM be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MTEM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MTEM
Looking for a Fast-paced Momentum Stock at a Bargain? Consider Molecular Templates Inc. (MTEM)
Will Molecular Templates Inc. (MTEM) Report Negative Q1 Earnings? What You Should Know
MTEM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Molecular Templates Inc. (MTEM) Reports Q4 Loss, Lags Revenue Estimates
Adherex Technologies Inc. (FENC) Reports Q4 Loss, Lags Revenue Estimates
Heron Therapeutics (HRTX) Reports Q4 Loss, Tops Revenue Estimates
Other News for MTEM
7 F-Rated Penny Stocks to Avoid This June
Molecular Templates, Inc. Provides Interim Update
Molecular Templates provides update on clinical-stage programs
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Molecular Templates, Inc. Reports First Quarter 2024 Financial Results and Corporate Update